An antibody that neutralizes all known COVID-19 variations has been identified by researchers.
SP1-77 is the outcome of a cooperative process between researchers at Boston Children's Hospital and Duke University.
SP1-77 is a research antibody that has so far been shown to neutralize all types of SARS-CoV-2, the virus that causes COVID-19.
It was developed after researchers modified a mouse model designed to look for broadly neutralizing antibodies to HIV, which also mutates.
It's unclear at the moment. It's worth noting that this study was conducted on mice rather on people, while research on the antibody is underway.
The researchers have registered for a patent for the SP1-77 antibody and mouse model used to produce it, and if everything goes well, they want to build something that the general public may utilize.